Human participants Collection and analyses of breast cancer tissue samples and matching blood samples were approved by the Israeli Ministry of Health Ethics Committees (Helsinki applications KMC-0028-22), followed by approval of the Weizmann Institutional Review Board (IRB, 2314-3). The breast cancer samples for histone PTM mass-spectrometry-based analysis, which comprise 21 tumours, were obtained from patients
